The market has been down on Johnson & Johnson (JNJ) stock recently. JNJ gets a Bearish score from Investors Observer Stock Sentiment Indicator.

Johnson & Johnson has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on JNJ!

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental ther analysis such as profitability of the company and means new earnings that Greatly impact overall sentiment. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish , while if it is going down, sentiment is bearish.

Investors Observer‘s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also Considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What’s Happening With JNJ Stock Today?

Johnson & Johnson (JNJ) stock is trading at $162.65 as of 3:04 PM on Tuesday, Jan 31, a rise of $0.65, or 0.4% from the previous closing price of $162.00. Volume today is 6,689,149 compared to average volume of 9,0.162,9 The stock has traded between $161.05 and $162.74 so far today. To screen for more stocks like Johnson & Johnson click here.

More About Johnson & Johnson

Johnson & Johnson is the world’s largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total sales are generated in the United States. Click Here to get the full Stock Report for Johnson & Johnson stock .